Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Raymond James 34th Annual Institutional Investors Conference in Orlando, Florida, on March 4, 2013. James C. Clemmer, President, Medical Supplies, will represent the Company in a presentation scheduled to begin at 8:40AM ET. A live audio webcast of the presentation can be accessed at Covidien’s Investor Relations website: http://investor.covidien.com. About Covidien Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2012 revenue of $11.9 billion, Covidien has 43,000 employees worldwide in 70 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.
Ikaria, which focuses on therapies for critically ill infants, is privately owned by a group led by Madison Dearborn Partners. Buyer Mallinckrodt specializes in diagnostic radiology and pain management.